Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH(1–34)
✍ Scribed by Yasuyuki Suzuki; Yoshinori Nagase; Katsumi Iga; Masahiro Kawase; Masahiro Oka; Shigeo Yanai; Yukihiro Matsumoto; Shizue Nakagawa; Tsunehiko Fukuda; Hirotoshi Adachi; Naruhito Higo; Yasuaki Ogawa
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 165 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
✦ Synopsis
Serum human parathyroid hormone (1±34)[hPTH(1±34)] levels and the anabolic effect of hPTH(1±34) were compared after administration using multiple pulses of iontophoresis or subcutaneous (sc) intermittent injections to ovariectomized (OVX) Sprague Dawley rats. Triple-pulse iontophoretic administration of hPTH(1±34) (doses: 40±400 mg/patch), achieved by repeated 30-min applications of a 0.1 mA/cm 2 current separated by 45-min rest intervals, produced three sharp peaks in the serum hPTH(1±34) level in response to application of the current. Each peak appeared at the end of the 30-min current application period and was proportional to the hPTH(1±34) dose. Compared with once-daily sc injections (7 pulses/week), triple-pulses iontophoretic administered 3 times/week (9 pulses/week) for 4 weeks produced dose-related increases in the bone mineral density (BMD) of the distal 1/3 femur. For the sc administration, the relative BMD values using the vehicle injection as a reference standard for 1, 5, and 25 mg/kg/day were 104, 114, and 121%, respectively. For iontophoretic administration, the relative BMD values using the placebo patch as a reference standard for 40, 120, and 400 mg/patch were 104, 110, and 116%, respectively. The increase in the BMD plotted against the area under the hPTH(1±34) serum level±time curve (AUC) over 1 week resulted in similar straight lines in the 9 pulses/week iontophoretic administration and the 7 pulses/week sc administration groups. The estimated iontophoretic dose giving an equivalent BMD to once-daily sc administration at 5 mg/kg/day was 120 mg/patch. These ®ndings strongly suggest that three iontophoretic pulses administered on alternate 350
📜 SIMILAR VOLUMES
Intermittent treatment with human parathyroid hormone (1-34) ] stimulates bone formation and increases cancellous bone mass in ovariectomized (OW) rats. But PTH-induced cancellous bone rapidly disappears upon cessation of treatment. The fate of cortical bone treated by PTH has not been well characte
To evaluate the potential use of a combination of parathyroid hormone (PTH) and estrogen as therapy for osteoporosis, we examined the effects of combined and separate administration of low-dose PTH and estradiol in ovariectomized rats with established osteopenia. Ovariectomized rats were untreated f